29 February 2024

Phage therapy awarded the Leenaards Foundation Prize for translational research

Alex Persat (EPFL), Angela Koutsokera (CHUV) and Grégory Resch (CHUV). Photo: Alban Kakulya

Our warmest congratulations to NCCR PI Grégory Resch for winning the 2024 Prize for translational biomedical research from the Leenaards Foundation, together with collaborators Angela Koutsokera (CHUV) and Alex Persat (EPFL), for the development of phage therapy to fight bacterial infections resistant to antibiotics!

This Prize will be awarded on 21 March in the AGORA building in Lausanne during the Leenaards Sciences & Health Meeting.